Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer (Q39363790)

11 September 2017

title

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer (English)

1 reference

11 September 2017

1 reference

1 reference

1 reference

7

1 reference

11 September 2017

A Balwierz

2

0 references

author name string

A Ward

1

1 reference

11 September 2017

J D Zhang

3

1 reference

11 September 2017

M Küblbeck

4

1 reference

11 September 2017

Y Pawitan

5

1 reference

11 September 2017

T Hielscher

6

1 reference

11 September 2017

Ö Sahin

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

16 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

32

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

1173-1182

1 reference

Modelling breast cancer: one size does not fit all.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Endocrine pharmacology of antiestrogens as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Mechanisms of tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Long-term exposure to tamoxifen induces hypersensitivity to estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Role of cell shape in growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Epithelial mesenchymal transition traits in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2012.128

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.128

1 reference

Dimensions Publication ID

11 September 2017

1050107557

0 references

1 reference